Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic pulmonary fibrosis (IPF) is one of more than 130 types of interstitial lung disease (ILD). It is described by scarring (fibrosis) of the lungs. The word “idiopathic” means “of unknown cause.”

National Jewish Health is the leading hospital in the nation. We treat hundreds of people with IPF and other types of pulmonary fibrosis each year. Our expertise is recognized by the Pulmonary Fibrosis Foundation (PFF). It has designated National Jewish Health as a PFF Care Center.

National Jewish Health also is a Specialized Center of ILD Research for the National Institutes of Health. This center conducts IPF research, so you have access to the latest clinical trials and most effective treatments.

Call 1.877.CALL.NJH

Our Patient Education Program at National Jewish Health provides many free educational opportunities and support groups to assist patients and caregivers with managing illnesses and chronic conditions.

Many patients who come to National Jewish Health are trying to find answers to ongoing health issues. Our doctors use advanced testing to accurately diagnose our patients’ conditions and determine the best treatment plan.

Living with Idiopathic Pulmonary Fibrosis

Clinical Trials

Idiopathic Pulmonary Fibrosis (IPF)

The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).

Patient Stories

Four years ago, Mark McCormick started having a persistent cough. His primary care doctor ordered a chest x-ray; however, he never received the results. A year later, Mark learned that he had idiopathic pulmonary fibrosis. “It took my breath away,” he said, but it didn’t stop him from seeking help and supporting other people like him.